Home |
About Us |
Investor Relations |
Products & Services |
Science & Technology |
People |
News & Events |
Contact Us
News |
Events
|
|
 |
|
||
 |
||
| |
|
 |
 |
14 August 2007 Cyprotex PLC (AIM:CRX), the drug discovery technology and information company, today announces that it has issued 10,398 new ordinary shares of 0.1p each (“new Ordinary Shares”) pursuant to the exercise of options. The issue of these new Ordinary shares is subject to the new Ordinary
Shares being admitted to trading on AIM, application for which has
been made. Trading in the new Ordinary Shares, which will rank pari
passu in all respects with the existing ordinary shares, is expected
to commence on 15 August 2007. For further information: Cyprotex PLC |
|
|
 |
|
 |
Legal
Disclaimer |